TY - JOUR
T1 - Prevention and treatment of relapse after stem cell transplantation with immunotherapy /692/699/1541/1990 /631/67 review-article
AU - Gökbuget, Nicola
AU - Canaani, Jonathan
AU - Nagler, Arnon
AU - Bishop, Michael
AU - Kröger, Nicolaus
AU - Avigan, David
N1 - Publisher Copyright:
© 2018 Macmillan Publishers Limited, part of Springer Nature.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.
AB - Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.
UR - http://www.scopus.com/inward/record.url?scp=85047335043&partnerID=8YFLogxK
U2 - 10.1038/s41409-018-0232-3
DO - 10.1038/s41409-018-0232-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 29795427
AN - SCOPUS:85047335043
SN - 0268-3369
VL - 53
SP - 664
EP - 672
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 6
ER -
